(-)-epigallocatechin 3-gallate increases expression ISO SLC31A1 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of SLC31A1 mRNA and epigallocatechin gallate results in increased expression of SLC31A1 protein CTD PMID:25927922 and PMID:27270317 (-)-epigallocatechin 3-gallate multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 epigallocatechin gallate inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] and epigallocatechin gallate results in increased expression of and affects the localization of SLC31A1 protein CTD PMID:25927922 and PMID:27270317 (1->4)-beta-D-glucan multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC31A1 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO SLC31A1 (Homo sapiens) 6480464 o and p'-DDT results in increased expression of SLC31A1 mRNA CTD PMID:19371625 1,2-dimethylhydrazine multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC31A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Slc31a1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SLC31A1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO Slc31a1 (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of SLC31A1 mRNA and Ethinyl Estradiol results in decreased expression of SLC31A1 protein CTD PMID:27690074 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC31A1 mRNA CTD PMID:26865667 17alpha-ethynylestradiol multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC31A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO Slc31a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of SLC31A1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 Estradiol inhibits the reaction [Copper results in decreased expression of SLC31A1 protein] and Estradiol promotes the reaction [Copper affects the expression of SLC31A1 mRNA] CTD PMID:19685012 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC31A1 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO SLC31A1 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC31A1 mRNA CTD PMID:19685012 17beta-estradiol 3-benzoate decreases expression EXP 6480464 estradiol 3-benzoate results in decreased expression of SLC31A1 mRNA CTD PMID:32741896 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO SLC31A1 (Homo sapiens) 6480464 Metribolone results in increased expression of SLC31A1 mRNA and Metribolone results in increased expression of SLC31A1 protein CTD PMID:25320179 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Metribolone results in increased expression of SLC31A1 protein] which results in increased import of Copper more ... CTD PMID:25320179 2,2,2-tetramine increases expression EXP 6480464 Trientine results in increased expression of SLC31A1 mRNA CTD PMID:22362149 2,2,2-tetramine increases expression ISO SLC31A1 (Homo sapiens) 6480464 Trientine results in increased expression of SLC31A1 mRNA and Trientine results in increased expression of SLC31A1 protein CTD PMID:22914438 2,2,2-tetramine multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Trientine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to oxaliplatin more ... CTD PMID:22491798 and PMID:22914438 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC31A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc31a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC31A1 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC31A1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC31A1 mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc31a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC31A1 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SLC31A1 mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Slc31a1 (Mus musculus) 6480464 3 more ... CTD PMID:19467301 3-Iodothyronamine affects uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SLC31A1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases methylation ISO Slc31a1 (Mus musculus) 6480464 bisphenol S results in decreased methylation of SLC31A1 exon CTD PMID:33297965 5-aza-2'-deoxycytidine increases expression ISO SLC31A1 (Homo sapiens) 6480464 Decitabine results in increased expression of SLC31A1 protein CTD PMID:19470736 aflatoxin B1 affects expression ISO SLC31A1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of SLC31A1 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO SLC31A1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SLC31A1 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLC31A1 mRNA CTD PMID:22100608 aflatoxin B1 decreases expression ISO Slc31a1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of SLC31A1 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO SLC31A1 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC31A1 mRNA CTD PMID:23724009 amiloride multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 Amiloride inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC31A1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of SLC31A1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO Slc31a1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC31A1 mRNA CTD PMID:23650126 bathocuproine disulfonic acid multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA and bathocuproine sulfonate promotes the reaction [SP1 protein results in increased expression of SLC31A1 mRNA] CTD PMID:18483225 benzo[a]pyrene increases expression ISO Slc31a1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC31A1 mRNA CTD PMID:21569818 and PMID:27195522 benzo[a]pyrene decreases methylation ISO SLC31A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of SLC31A1 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC31A1 mRNA CTD PMID:26238291 and PMID:32234424 benzo[a]pyrene decreases expression ISO Slc31a1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC31A1 mRNA CTD PMID:22228805 bisphenol A increases expression ISO SLC31A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of SLC31A1 mRNA CTD PMID:19371625 bisphenol A decreases expression ISO Slc31a1 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC31A1 mRNA and bisphenol A results in decreased expression of SLC31A1 protein CTD PMID:27690074 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC31A1 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC31A1 mRNA CTD PMID:26496021 bortezomib multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Bortezomib inhibits the reaction [Cisplatin results in decreased expression of SLC31A1 protein]] which results in increased uptake of Cisplatin more ... CTD PMID:19147760 and PMID:24209693 bortezomib decreases degradation ISO SLC31A1 (Homo sapiens) 6480464 Bortezomib results in decreased degradation of SLC31A1 protein CTD PMID:24209693 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SLC31A1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC31A1 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO SLC31A1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of SLC31A1 mRNA CTD PMID:26472689 cadmium dichloride multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC31A1 mRNA CTD PMID:35301059 carboplatin decreases response to substance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 gene mutant form results in decreased susceptibility to Carboplatin CTD PMID:16847145 carboplatin multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Penicillamine results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Carboplatin more ... CTD PMID:22914438 carboplatin increases import EXP 6480464 SLC31A1 protein results in increased import of Carboplatin CTD PMID:23123662 carboplatin increases uptake ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased uptake of Carboplatin CTD PMID:16847145 and PMID:19509135 carboplatin increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased uptake of Carboplatin CTD PMID:15634647 carboplatin increases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased susceptibility to Carboplatin CTD PMID:15634647 carnosine decreases expression EXP 6480464 Carnosine results in decreased expression of SLC31A1 mRNA and Carnosine results in decreased expression of SLC31A1 protein CTD PMID:30485136 carnosine decreases expression ISO Slc31a1 (Mus musculus) 6480464 Carnosine results in decreased expression of SLC31A1 mRNA and Carnosine results in decreased expression of SLC31A1 protein CTD PMID:30485136 casticin increases expression ISO Slc31a1 (Mus musculus) 6480464 casticin results in increased expression of SLC31A1 mRNA CTD PMID:28444820 celecoxib multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Celecoxib results in decreased expression of SLC31A1 protein] which results in decreased import of and results in decreased susceptibility to Cisplatin CTD PMID:21177414 celecoxib decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Celecoxib results in decreased expression of SLC31A1 protein CTD PMID:21177414 celecoxib affects expression ISO Slc31a1 (Mus musculus) 6480464 Celecoxib affects the expression of SLC31A1 mRNA CTD PMID:20562220 chlorpromazine multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 Chlorpromazine inhibits the reaction [Copper affects the localization of SLC31A1 protein] CTD PMID:12501239 chromium(6+) affects expression ISO Slc31a1 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC31A1 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased expression of SLC31A1 protein] which results in decreased import of and results in decreased susceptibility to Cisplatin more ... CTD PMID:17108132 more ... cisplatin decreases expression ISO Slc31a1 (Mus musculus) 6480464 Cisplatin results in decreased expression of SLC31A1 mRNA CTD PMID:31493026 cisplatin increases expression ISO SLC31A1 (Homo sapiens) 6480464 [Cisplatin results in increased expression of SP1 protein] which results in increased expression of SLC31A1 mRNA more ... CTD PMID:22914438 and PMID:24132751 cisplatin increases import ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased import of Cisplatin CTD PMID:24132751 cisplatin increases import EXP 6480464 SLC31A1 protein results in increased import of Cisplatin CTD PMID:23123662 cisplatin decreases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in decreased susceptibility to Cisplatin CTD PMID:24800945 cisplatin decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Cisplatin results in decreased expression of SLC31A1 protein CTD PMID:19147760 and PMID:24800945 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SLC31A1 mRNA CTD PMID:26739623 cisplatin increases degradation ISO SLC31A1 (Homo sapiens) 6480464 Cisplatin results in increased degradation of SLC31A1 protein CTD PMID:17108132 more ... cisplatin increases uptake ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased uptake of Cisplatin CTD PMID:16847145 more ... cisplatin increases response to substance EXP 6480464 SLC31A1 protein results in increased susceptibility to Cisplatin CTD PMID:19144690 cisplatin increases transport ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased transport of Cisplatin CTD PMID:19570948 cisplatin affects response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 mRNA affects the susceptibility to Cisplatin and SLC31A1 protein affects the susceptibility to Cisplatin CTD PMID:18610736 and PMID:22914438 cisplatin increases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in increased susceptibility to Cisplatin and SLC31A1 protein results in increased susceptibility to Cisplatin CTD PMID:15634647 more ... cisplatin increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in increased uptake of Cisplatin and SLC31A1 protein results in increased uptake of Cisplatin CTD PMID:15634647 more ... cisplatin decreases response to substance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 gene mutant form results in decreased susceptibility to Cisplatin CTD PMID:16847145 cisplatin multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [Copper Sulfate results in decreased activity of SLC31A1 protein] which results in decreased uptake of Cisplatin and SLC31A1 gene mutant form results in decreased uptake of and results in decreased susceptibility to Cisplatin CTD PMID:16170571 and PMID:20631178 cisplatin affects uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein affects the uptake of Cisplatin CTD PMID:15985617 and PMID:27270317 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC31A1 mRNA CTD PMID:17602206 cobalt dichloride multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 mutant form inhibits the reaction [cobaltous chloride results in decreased expression of CDH1 protein] and SLC31A1 mutant form inhibits the reaction [cobaltous chloride results in increased expression of VIM mRNA] CTD PMID:26174737 cobalt dichloride increases expression ISO SLC31A1 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of SLC31A1 mRNA CTD PMID:24614111 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:15591161 more ... copper atom increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in increased uptake of Copper and SLC31A1 protein results in increased uptake of Copper CTD PMID:12177073 more ... copper atom affects localization ISO SLC31A1 (Homo sapiens) 6480464 Copper affects the localization of SLC31A1 protein CTD PMID:12501239 more ... copper atom increases import ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23426973 more ... copper atom increases import EXP 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23123662 copper atom decreases abundance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein modified form results in decreased abundance of Copper CTD PMID:24167251 copper atom increases abundance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased abundance of Copper CTD PMID:24522273 copper atom increases uptake EXP 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:24316150 copper atom increases transport EXP 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:22465424 copper atom increases uptake ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:11391004 more ... copper atom affects uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein affects the uptake of Copper CTD PMID:12872841 copper atom increases transport ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:12220667 more ... copper atom increases degradation ISO SLC31A1 (Homo sapiens) 6480464 Copper results in increased degradation of SLC31A1 protein CTD PMID:12501239 and PMID:17108132 copper atom affects abundance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 gene mutant form affects the abundance of Copper CTD PMID:12177073 copper atom decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Copper results in decreased expression of SLC31A1 mRNA and Copper results in decreased expression of SLC31A1 protein CTD PMID:18483225 more ... copper atom increases expression ISO SLC31A1 (Homo sapiens) 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:18483225 more ... copper atom multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA more ... CTD PMID:12501239 more ... copper atom decreases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in decreased susceptibility to Copper CTD PMID:20519567 copper atom decreases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 mutant form results in decreased uptake of Copper CTD PMID:23543413 copper atom decreases transport ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in decreased transport of Copper CTD PMID:20519567 copper atom multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [ATP7B gene mutant form results in decreased export of Copper] which results in decreased expression of SLC31A1 protein more ... CTD PMID:12177073 more ... copper atom affects transport ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein affects the transport of Copper CTD PMID:17268249 copper atom increases secretion EXP 6480464 SLC31A1 protein results in increased secretion of Copper CTD PMID:16741141 copper atom multiple interactions EXP 6480464 Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] more ... CTD PMID:16741141 more ... copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:15591161 more ... copper(0) increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in increased uptake of Copper and SLC31A1 protein results in increased uptake of Copper CTD PMID:12177073 more ... copper(0) affects localization ISO SLC31A1 (Homo sapiens) 6480464 Copper affects the localization of SLC31A1 protein CTD PMID:12501239 more ... copper(0) increases import ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23426973 more ... copper(0) increases import EXP 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23123662 copper(0) decreases abundance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein modified form results in decreased abundance of Copper CTD PMID:24167251 copper(0) increases abundance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased abundance of Copper CTD PMID:24522273 copper(0) increases uptake EXP 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:24316150 copper(0) increases transport EXP 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:22465424 copper(0) increases uptake ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:11391004 more ... copper(0) affects uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein affects the uptake of Copper CTD PMID:12872841 copper(0) increases transport ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:12220667 more ... copper(0) increases degradation ISO SLC31A1 (Homo sapiens) 6480464 Copper results in increased degradation of SLC31A1 protein CTD PMID:12501239 and PMID:17108132 copper(0) affects abundance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 gene mutant form affects the abundance of Copper CTD PMID:12177073 copper(0) decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Copper results in decreased expression of SLC31A1 mRNA and Copper results in decreased expression of SLC31A1 protein CTD PMID:18483225 more ... copper(0) increases expression ISO SLC31A1 (Homo sapiens) 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:18483225 more ... copper(0) multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA more ... CTD PMID:12501239 more ... copper(0) decreases transport ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in decreased transport of Copper CTD PMID:20519567 copper(0) decreases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 mutant form results in decreased uptake of Copper CTD PMID:23543413 copper(0) decreases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein mutant form results in decreased susceptibility to Copper CTD PMID:20519567 copper(0) multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [ATP7B gene mutant form results in decreased export of Copper] which results in decreased expression of SLC31A1 protein more ... CTD PMID:12177073 more ... copper(0) affects transport ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein affects the transport of Copper CTD PMID:17268249 copper(0) increases secretion EXP 6480464 SLC31A1 protein results in increased secretion of Copper CTD PMID:16741141 copper(0) multiple interactions EXP 6480464 Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] more ... CTD PMID:16741141 more ... copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of SLC31A1 protein CTD PMID:24316150 copper(II) chloride multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased susceptibility to [cupric chloride results in increased abundance of Copper] CTD PMID:32278528 copper(II) chloride decreases expression ISO SLC31A1 (Homo sapiens) 6480464 cupric chloride results in decreased expression of SLC31A1 protein CTD PMID:24800945 copper(II) sulfate multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [Copper Sulfate results in decreased activity of SLC31A1 protein] which results in decreased uptake of Cisplatin more ... CTD PMID:20631178 and PMID:22842628 copper(II) sulfate decreases expression ISO SLC31A1 (Homo sapiens) 6480464 [Copper Sulfate results in decreased expression of SP1 mRNA] which results in decreased expression of SLC31A1 mRNA and Copper Sulfate results in decreased expression of SLC31A1 mRNA CTD PMID:19549813 more ... copper(II) sulfate multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 Copper Sulfate inhibits the reaction [Cisplatin results in increased expression of SLC31A1 mRNA] more ... CTD PMID:22172574 and PMID:24132751 copper(II) sulfate decreases activity ISO Slc31a1 (Mus musculus) 6480464 Copper Sulfate results in decreased activity of SLC31A1 protein CTD PMID:20631178 coumestrol increases expression ISO SLC31A1 (Homo sapiens) 6480464 Coumestrol results in increased expression of SLC31A1 mRNA CTD PMID:19167446 CU-O LINKAGE increases expression ISO SLC31A1 (Homo sapiens) 6480464 cupric oxide analog results in increased expression of SLC31A1 mRNA and cupric oxide analog results in increased expression of SLC31A1 protein CTD PMID:24815816 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of SLC31A1 mRNA CTD PMID:27523638 cytochalasin D multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 Cytochalasin D inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 D-penicillamine multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Penicillamine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to Oxaliplatin more ... CTD PMID:22914438 D-penicillamine increases expression ISO SLC31A1 (Homo sapiens) 6480464 Penicillamine results in increased expression of SLC31A1 mRNA CTD PMID:22914438 diazinon increases methylation ISO SLC31A1 (Homo sapiens) 6480464 Diazinon results in increased methylation of SLC31A1 gene CTD PMID:22964155 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC31A1 mRNA CTD PMID:21658437 dioxygen multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [Oxygen deficiency results in increased expression of SLC31A1 protein] which results in increased uptake of Copper CTD PMID:19351718 dioxygen multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of SLC31A1 mRNA] CTD PMID:24614111 dioxygen increases expression ISO SLC31A1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC31A1 mRNA CTD PMID:24614111 dioxygen increases expression ISO Slc31a1 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of SLC31A1 mRNA and Oxygen deficiency results in increased expression of SLC31A1 protein CTD PMID:19351718 and PMID:24614111 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC31A1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A1 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC31A1 mRNA CTD PMID:23649840 folic acid multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC31A1 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC31A1 mRNA CTD PMID:23649840 fructose multiple interactions EXP 6480464 Fructose inhibits the reaction [Copper deficiency results in increased expression of SLC31A1 protein] CTD PMID:21781943 fumonisin B1 decreases expression ISO Slc31a1 (Mus musculus) 6480464 fumonisin B1 results in decreased expression of SLC31A1 mRNA CTD PMID:16221962 genistein increases expression ISO SLC31A1 (Homo sapiens) 6480464 Genistein results in increased expression of SLC31A1 mRNA CTD PMID:19371625 and PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC31A1 mRNA CTD PMID:33387578 glutathione multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23426973 graphite affects expression EXP 6480464 Graphite affects the expression of SLC31A1 mRNA CTD PMID:29933104 hydrogen peroxide multiple interactions ISO Slc31a1 (Mus musculus) 6480464 Hydrogen Peroxide inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]] and Hydrogen Peroxide inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] CTD PMID:22842628 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of SLC31A1 mRNA CTD PMID:20097248 isotretinoin decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of SLC31A1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of SLC31A1 protein CTD PMID:32959892 lactacystin multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 lactacystin inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 lamivudine multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA CTD PMID:15784690 lead diacetate multiple interactions EXP 6480464 lead acetate promotes the reaction [SLC31A1 protein results in increased uptake of Copper] and lead acetate results in increased expression of and affects the localization of SLC31A1 protein CTD PMID:24316150 and PMID:25579025 lead diacetate increases expression ISO Slc31a1 (Mus musculus) 6480464 lead acetate results in increased expression of SLC31A1 mRNA and lead acetate results in increased expression of SLC31A1 protein CTD PMID:30623991 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC31A1 mRNA and lead acetate results in increased expression of SLC31A1 protein CTD PMID:24316150 and PMID:25579025 lead(0) multiple interactions EXP 6480464 SLC31A1 mutant form inhibits the reaction [Lead results in decreased export of Copper] CTD PMID:24316150 lipopolysaccharide increases expression ISO Slc31a1 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of SLC31A1 mRNA CTD PMID:22369063 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of SLC31A1 mRNA CTD PMID:26739623 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC31A1 mRNA CTD PMID:28801915 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC31A1 mRNA CTD PMID:30467583 methyl beta-cyclodextrin multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 methyl-beta-cyclodextrin inhibits the reaction [Copper affects the localization of SLC31A1 protein] CTD PMID:12501239 methyl methanesulfonate decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC31A1 mRNA CTD PMID:23649840 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of SLC31A1 mRNA CTD PMID:28349193 methylmercury chloride increases expression ISO SLC31A1 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of SLC31A1 mRNA CTD PMID:28001369 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC31A1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC31A1 mRNA CTD PMID:17602206 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of SLC31A1 mRNA and nitrofen results in decreased expression of SLC31A1 protein CTD PMID:25319798 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC31A1 protein CTD PMID:20836889 oxaliplatin multiple interactions EXP 6480464 copper histidine inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] and Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] CTD PMID:23123662 and PMID:23556474 oxaliplatin increases uptake ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 protein results in increased uptake of oxaliplatin CTD PMID:16847145 oxaliplatin decreases response to substance ISO Slc31a1 (Mus musculus) 6480464 SLC31A1 gene mutant form results in decreased susceptibility to oxaliplatin CTD PMID:16847145 oxaliplatin increases import EXP 6480464 SLC31A1 protein results in increased import of oxaliplatin CTD PMID:23123662 oxaliplatin affects response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein affects the susceptibility to oxaliplatin CTD PMID:16773204 oxaliplatin multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Penicillamine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to oxaliplatin more ... CTD PMID:22914438 oxaliplatin increases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased susceptibility to oxaliplatin CTD PMID:15634647 oxaliplatin increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased uptake of oxaliplatin CTD PMID:15634647 paclitaxel increases expression ISO SLC31A1 (Homo sapiens) 6480464 Paclitaxel results in increased expression of SLC31A1 mRNA CTD PMID:20737486 paracetamol affects expression ISO Slc31a1 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC31A1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC31A1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC31A1 mRNA CTD PMID:21420995 paraquat decreases response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 gene results in decreased susceptibility to Paraquat CTD PMID:29058724 paraquat increases expression ISO SLC31A1 (Homo sapiens) 6480464 Paraquat results in increased expression of SLC31A1 mRNA CTD PMID:34097952 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc31a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC31A1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC31A1 mRNA CTD PMID:36331819 phenylmercury acetate increases expression ISO SLC31A1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SLC31A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A1 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO Slc31a1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC31A1 mRNA CTD PMID:18445702 and PMID:23811191 platinum affects response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 affects the susceptibility to Platinum CTD PMID:21570711 platinum increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased uptake of Platinum CTD PMID:22491798 platinum multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Bortezomib results in decreased degradation of SLC31A1 protein] which results in increased uptake of Platinum and Trientine promotes the reaction [SLC31A1 protein results in increased uptake of Platinum] CTD PMID:22491798 and PMID:24209693 platinum(0) affects response to substance ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 affects the susceptibility to Platinum CTD PMID:21570711 platinum(0) multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Bortezomib results in decreased degradation of SLC31A1 protein] which results in increased uptake of Platinum and Trientine promotes the reaction [SLC31A1 protein results in increased uptake of Platinum] CTD PMID:22491798 and PMID:24209693 platinum(0) increases uptake ISO SLC31A1 (Homo sapiens) 6480464 SLC31A1 protein results in increased uptake of Platinum CTD PMID:22491798 rac-lactic acid decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of SLC31A1 mRNA CTD PMID:30851411 resveratrol increases expression ISO SLC31A1 (Homo sapiens) 6480464 resveratrol results in increased expression of SLC31A1 mRNA CTD PMID:19371625 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [SLC31A1 protein results in increased import of Copper] more ... CTD PMID:23426973 SB 431542 multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A1 mRNA CTD PMID:27188386 silver atom multiple interactions EXP 6480464 Silver inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662 silver(0) multiple interactions EXP 6480464 Silver inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662 silver(1+) nitrate increases expression ISO SLC31A1 (Homo sapiens) 6480464 Silver Nitrate results in increased expression of SLC31A1 mRNA CTD PMID:24132751 sirolimus multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 Sirolimus affects the reaction [SLC31A1 protein affects the expression of BAX protein] more ... CTD PMID:37290678 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SLC31A1 mRNA CTD PMID:22561333 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of SLC31A1 mRNA and Streptozocin results in decreased expression of SLC31A1 protein CTD PMID:24927960 tamoxifen affects expression ISO Slc31a1 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC31A1 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO Slc31a1 (Mus musculus) 6480464 tert-Butylhydroperoxide results in decreased expression of SLC31A1 mRNA CTD PMID:14729362 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC31A1 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO Slc31a1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC31A1 mRNA CTD PMID:31919559 tetrathiomolybdate(2-) multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [tetrathiomolybdate results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to oxaliplatin more ... CTD PMID:22172574 and PMID:22914438 tetrathiomolybdate(2-) decreases expression ISO SLC31A1 (Homo sapiens) 6480464 tetrathiomolybdate results in decreased expression of SLC31A1 protein CTD PMID:37290678 tetrathiomolybdate(2-) increases expression ISO SLC31A1 (Homo sapiens) 6480464 tetrathiomolybdate results in increased expression of SLC31A1 mRNA CTD PMID:22914438 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC31A1 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO Slc31a1 (Mus musculus) 6480464 titanium dioxide affects the expression of SLC31A1 mRNA CTD PMID:17656681 trichostatin A affects expression ISO SLC31A1 (Homo sapiens) 6480464 trichostatin A affects the expression of SLC31A1 mRNA CTD PMID:28542535 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of SLC31A1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO SLC31A1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of SLC31A1 gene CTD PMID:29154799 vanadium atom decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Vanadium results in decreased expression of SLC31A1 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Vanadium results in decreased expression of SLC31A1 mRNA CTD PMID:19000753 Y-27632 decreases expression ISO SLC31A1 (Homo sapiens) 6480464 Y 27632 results in decreased expression of SLC31A1 mRNA CTD PMID:20878077 zearalenone increases expression ISO SLC31A1 (Homo sapiens) 6480464 Zearalenone results in increased expression of SLC31A1 mRNA CTD PMID:19371625 zidovudine multiple interactions ISO SLC31A1 (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA CTD PMID:15784690 zinc acetate increases expression ISO SLC31A1 (Homo sapiens) 6480464 Zinc Acetate results in increased expression of SLC31A1 mRNA CTD PMID:24132751 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662